Global Gene Therapy Market Analysis & Forecast to 2022: $350+ Million Market Strengthened by Recent Approvals of … – GlobeNewswire (press release)
|
Global Gene Therapy Market Analysis & Forecast to 2022: $350+ Million Market Strengthened by Recent Approvals of …
GlobeNewswire (press release) Strengthened by recent approvals of Kymriah, Yescarta and Luxturna in the US, and a committed European, Japanese and Chinese environment, gene therapy is set to become a significant player in the bio-pharmaceutical industry. The space covers many … |
